type 2 diabetes

Alnylam boots Type 2 diabetes asset from haunted house
Fierce Biotech
Fri, 11/1/24 - 11:09 am
Alnylam
RNAi
type 2 diabetes
Chinese insulin maker says its GLP-1 beat Ozempic at lowering blood sugar, body weight in phase 2
Fierce Biotech
Wed, 10/16/24 - 12:17 pm
Gan & Lee
GLP-1
Novo Nordisk
Ozempic
type 2 diabetes
Ozempic linked to lower opioid overdose rate in those with diabetes, study shows
Stat
Wed, 09/25/24 - 12:04 pm
Novo Nordisk
Ozempic
opioid addiction
Rybelsus
type 2 diabetes
Insulet’s Trang Ly on overcoming ‘clinical inertia’ in diabetes care
Medtech Dive
Wed, 08/28/24 - 09:14 pm
Medtech
Insulet
type 2 diabetes
insulin pumps
Lilly’s tirzepatide cuts diabetes risk, study data show
BioPharma Dive
Tue, 08/20/24 - 11:54 am
Eli Lilly
tirzepatide
Mounjaro
Zepbound
type 2 diabetes
diabetes
clinical trials
Insulet plans label expansion for Omnipod in type 2 diabetes
Clinical Trials Arena
Tue, 06/25/24 - 11:10 am
Medtech
Insulet
Omnipod 5
type 2 diabetes
Teva launches generic version of Novo Nordisk's diabetes drug Victoza
Reuters
Mon, 06/24/24 - 10:12 pm
Teva Pharmaceutical
Novo Nordisk
Victoza
type 2 diabetes
generics
Lilly wins NICE endorsement for tirzepatide in obesity—with a catch
Fierce Pharma
Tue, 06/4/24 - 11:38 am
Eli Lilly
UK
NICE
tirzepatide
obesity
type 2 diabetes
diabetes
Novo Nordisk's Ozempic slows diabetic kidney disease progression in trial
Reuters
Fri, 05/24/24 - 11:30 am
Novo Nordisk
Ozempic
kidney disease
diabetes
type 2 diabetes
Lilly's next-gen obesity drug brings Innovent a phase 3 win in diabetes
Fierce Biotech
Thu, 05/9/24 - 11:48 am
Innovent
Eli Lilly
mazdutide
obesity
type 2 diabetes
Boehringer, Walgreens Team Up for Obesity Trial as Weight-Loss Drug Race Heats Up
BioSpace
Mon, 05/6/24 - 11:33 am
Boehringer Ingelheim
Walgreens
obesity
type 2 diabetes
clinical trials
survodutide
Denmark to restrict Ozempic, other GLP-1 drugs, to treat type 2 diabetes
Reuters
Wed, 05/1/24 - 09:33 am
Denmark
type 2 diabetes
GLP-1 agonists
Novo Nordisk
Ozempic
Key opinion leaders on GLP-1 receptor agonist clinical trial design
Clinical Trials Arena
Fri, 04/26/24 - 11:41 am
clinical trials
GLP-1 agonist
type 2 diabetes
obesity
Ozempic not tied to pancreatic cancer risk, study suggests
Beckers Hospital Review
Tue, 01/9/24 - 10:04 pm
Ozempic
Trulicity
type 2 diabetes
Novo Nordisk
GLP-1 agonist
pancreatic cancer
US diabetes patients face delays as insurers tighten Ozempic coverage
Reuters
Tue, 12/12/23 - 10:03 am
Novo Nordisk
type 2 diabetes
Ozempic
insurers
GE HealthCare, Novo Nordisk partner to treat diabetes and obesity with ultrasound
Mass Device
Fri, 10/20/23 - 10:14 am
Medtech
GE Healthcare
Novo Nordisk
PFUS
ultrasound
obesity
type 2 diabetes
Eli Lilly infiltrates anti-obesity market as Phase III trial for retatrutide begins
Clinical Trials Arena
Thu, 08/31/23 - 06:02 pm
Eli Lilly
retatrutide
clinical trials
NASH
obesity
diabetes
type 2 diabetes
TheracosBio reports data from trial of diabetes therapy
Clinical Trials Arena
Mon, 08/7/23 - 12:00 pm
TheracosBio
diabetes
type 2 diabetes
Brenzavvy
clinical trials
FDA Approves New Class of Medicines to Treat Pediatric Type 2 Diabetes
Benzinga
Tue, 06/20/23 - 09:46 pm
Eli Lilly
Boehringer Ingelheim
Jardiance
Synjardy
type 2 diabetes
pediatric
FDA
AstraZeneca drops another GLP-1 after phase 1 data bust market-beating diabetes hopes
Fierce Biotech
Tue, 06/20/23 - 10:15 am
AstraZeneca
GLP-1 agonist
AZD0186
type 2 diabetes

Pages